- Home
- OPY vs MPLT Comparison
OPY vs MPLT Comparison
Compare OPY & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPY
- MPLT
- Stock Information
- Founded
- OPY 1881
- MPLT 2018
- Country
- OPY United States
- MPLT United States
- Employees
- OPY N/A
- MPLT N/A
- Industry
- OPY Investment Bankers/Brokers/Service
- MPLT Biotechnology: Pharmaceutical Preparations
- Sector
- OPY Finance
- MPLT Health Care
- Exchange
- OPY Nasdaq
- MPLT Nasdaq
- Market Cap
- OPY 730.3M
- MPLT 700.6M
- IPO Year
- OPY N/A
- MPLT 2025
- Fundamental
- Price
- OPY $67.75
- MPLT $15.63
- Analyst Decision
- OPY
- MPLT
- Analyst Count
- OPY 0
- MPLT 0
- Target Price
- OPY N/A
- MPLT N/A
- AVG Volume (30 Days)
- OPY 40.3K
- MPLT 634.6K
- Earning Date
- OPY 10-31-2025
- MPLT 11-28-2025
- Dividend Yield
- OPY 1.06%
- MPLT N/A
- EPS Growth
- OPY 16.17
- MPLT N/A
- EPS
- OPY 7.46
- MPLT N/A
- Revenue
- OPY $1,453,063,000.00
- MPLT N/A
- Revenue This Year
- OPY N/A
- MPLT N/A
- Revenue Next Year
- OPY N/A
- MPLT N/A
- P/E Ratio
- OPY $9.11
- MPLT N/A
- Revenue Growth
- OPY 13.48
- MPLT N/A
- 52 Week Low
- OPY $49.26
- MPLT $14.00
- 52 Week High
- OPY $79.99
- MPLT $20.86
- Technical
- Relative Strength Index (RSI)
- OPY 41.87
- MPLT N/A
- Support Level
- OPY $66.03
- MPLT N/A
- Resistance Level
- OPY $69.11
- MPLT N/A
- Average True Range (ATR)
- OPY 2.24
- MPLT 0.00
- MACD
- OPY 0.03
- MPLT 0.00
- Stochastic Oscillator
- OPY 16.28
- MPLT 0.00
About OPY Oppenheimer Holdings Inc. (DE)
Oppenheimer Holdings Inc conducts activities in the securities industry. The company is involved in retail securities brokerage, investment banking (both corporate and public finance), institutional sales and trading, market-making, research, trust services, and investment advisory and asset management services. The company has two segments: Wealth Management, and Capital Markets. IT generates maximum revenue from Wealth Management Segment which includes commissions and fee income earned on assets under management (AUM), net interest earnings on client margin loans and cash balances, fees from money market funds, custodian fees and other activities. The company generates the majority of its revenue from the Americas, with the rest from Europe, the Middle East, and Asia.
About MPLT MapLight Therapeutics Inc. Common Stock
MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.